Company · founded 2007
Fate Therapeutics (United States)
San Diego, United States · fatetherapeutics.com
- Citations, last 5 years
- 1 203
- Works, last 5 years
- 100
- h-index
- 86
- Scientists listed
- 22
- Grants since 2016
- 8
Grants received
2022–2025 · cooperative agreement · Cooperative Agreement
SBIR Phase II: Development Of An Orally Administered Gene Therapy For Granulocyte Colony-Stimulating Factor
Timothy Day · Fate Therapeutics (United States) · funded by National Science Foundation
2019–2020 · grant · Standard Grant
SBIR Phase I: Development Of An Orally Administered Gene Delivery Platform For Induced Protein Secretion Via The Gastrointestinal Tract
Timothy Day · Fate Therapeutics (United States) · funded by National Science Foundation
2018–2020 · research · R43
Exploiting activation-induced cell death as a means of inducing tolerance to kidney allografts
Robert Ray Redfield · Fate Therapeutics (United States) · funded by National Institutes of Health
2017–2019 · research · R41
Personalized Neural Stem Cell Therapy for Cancer
Susan Nichols · Fate Therapeutics (United States) · funded by National Institutes of Health
2017–2020 · research · R42
Personalized Neural Stem Cell Therapy for Cancer
Susan Nichols · Fate Therapeutics (United States) · funded by National Institutes of Health
2017–2019 · research · R41
SA-FasL-engineered human islets as a novel product for the treatment of type 1 diabetes
Esma S Yolcu · Fate Therapeutics (United States) · funded by National Institutes of Health
2017–2021 · research · R42
Personalized Neural Stem Cell Therapy for Cancer
Susan Nichols · Fate Therapeutics (United States) · funded by National Institutes of Health
2016–2019 · research · R41
Developing a novel adjuvant system for therapeutic vaccines against lung cancer
Haval Shirwan · Fate Therapeutics (United States) · funded by National Institutes of Health